You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 24, December 24/31, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (43)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Bacterial Infections
 •Prognosis/ Outcomes
 •Cardiovascular Intervention
 •Cardiovascular Interventions, Other
 •Alert me on articles by topic

Impact of Valve Surgery on 6-Month Mortality in Adults With Complicated, Left-Sided Native Valve Endocarditis

A Propensity Analysis

Holenarasipur R. Vikram, MD; Joan Buenconsejo, MPH; Rodrigo Hasbun, MD; Vincent J. Quagliarello, MD

JAMA. 2003;290:3207-3214.

Context  Complicated, left-sided native valve endocarditis causes significant morbidity and mortality in adults. The presumed benefits of valve surgery remain unproven due to lack of randomized controlled trials.

Objective  To determine whether valve surgery is associated with reduced mortality in adults with complicated, left-sided native valve endocarditis.

Design and Setting  Retrospective, observational cohort study conducted from January 1990 to January 2000 at 7 Connecticut hospitals. Propensity analyses were used to control for bias in treatment assignment and prognostic imbalances.

Patients  Of the 513 adults with complicated, left-sided native valve endocarditis, 230 (45%) underwent valve surgery and 283 (55%) received medical therapy alone.

Main Outcome Measure  All-cause mortality at 6 months after baseline.

Results  In the 6-month period after baseline, 131 patients (26%) died. In unadjusted analyses, valve surgery was associated with reduced mortality (16% vs 33%; hazard ratio [HR], 0.43; 95% confidence interval [CI], 0.29-0.63; P<.001). After adjustment for baseline variables associated with mortality (including hospital site, comorbidity, congestive heart failure, microbial etiology, immunocompromised state, abnormal mental status, and refractory infection), valve surgery remained associated with reduced mortality (adjusted HR, 0.35; 95% CI, 0.23-0.54; P<.02). In further analyses of 218 patients matched by propensity scores, valve surgery remained associated with reduced mortality (15% vs 28%; HR, 0.45; 95% CI, 0.23-0.86; P = .01). After additional adjustment for variables that contribute to heterogeneity and confounding within the propensity-matched group, surgical therapy remained significantly associated with a lower mortality (HR, 0.40; 95% CI, 0.18-0.91; P = .03). In this propensity-matched group, patients with moderate to severe congestive heart failure showed the greatest reduction in mortality with valve surgery (14% vs 51%; HR, 0.22; 95% CI, 0.09-0.53; P = .001).

Conclusions  Valve surgery for patients with complicated, left-sided native valve endocarditis was independently associated with reduced 6-month mortality after adjustment for both baseline variables associated with the propensity to undergo valve surgery and baseline variables associated with mortality. The reduced mortality was particularly evident among patients with moderate to severe congestive heart failure.


Author Affiliations: Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn. Dr Vikram is now with Infectious Disease Section, Hospital of St Raphael, New Haven, Conn. Ms Buenconsejo is now with Yale University School of Epidemiology and Public Health, New Haven, Conn. Dr Hasbun is now with Infectious Disease Section, Tulane University School of Medicine, New Orleans, La.


RELATED ARTICLE

Evaluating and Optimizing Outcomes of Surgery for Endocarditis
David T. Durack
JAMA. 2003;290(24):3250-3251.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Surgical therapy in patients with active infective endocarditis: seven-year single centre experience in a subgroup of 255 patients treated with the Shelhigh(R) stentless bioprosthesis
Musci et al.
Eur. J. Cardiothorac. Surg. 2008;34:410-417.
ABSTRACT | FULL TEXT  

The association between the timing of valve surgery and 6-month mortality in left-sided infective endocarditis
Tleyjeh et al.
Heart 2008;94:892-896.
ABSTRACT | FULL TEXT  

Echocardiographic risk stratification for early surgery with endocarditis: a cost-effectiveness analysis
Liao et al.
Heart 2008;94:e18-e18.
ABSTRACT | FULL TEXT  

Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience
Musci et al.
Eur. J. Cardiothorac. Surg. 2007;32:118-125.
ABSTRACT | FULL TEXT  

Epidemiology and Clinical Outcomes of Infective Endocarditis in Hemodialysis Patients
Kamalakannan et al.
Ann. Thorac. Surg. 2007;83:2081-2086.
ABSTRACT | FULL TEXT  

The Impact of Valve Surgery on 6-Month Mortality in Left-Sided Infective Endocarditis
Tleyjeh et al.
Circulation 2007;115:1721-1728.
ABSTRACT | FULL TEXT  

Predictors of Death and Impact of Surgery in Staphylococcus aureus Infective Endocarditis
Remadi et al.
Ann. Thorac. Surg. 2007;83:1295-1302.
ABSTRACT | FULL TEXT  

Contemporary Clinical Profile and Outcome of Prosthetic Valve Endocarditis
Wang et al.
JAMA 2007;297:1354-1361.
ABSTRACT | FULL TEXT  

Diabetes mellitus and infective endocarditis: the insulin factor in patient morbidity and mortality
Duval et al.
Eur Heart J 2007;28:59-64.
ABSTRACT | FULL TEXT  

The changing face of infective endocarditis.
Cecchi et al.
Heart 2006;92:1365-1366.
ABSTRACT | FULL TEXT  

Management of infective endocarditis
Habib
Heart 2006;92:124-130.
FULL TEXT  

Surgical Treatment of Mitral Valve Endocarditis in North America
Gammie et al.
Ann. Thorac. Surg. 2005;80:2199-2204.
ABSTRACT | FULL TEXT  

Infective Endocarditis: Global, Regional, and Future Perspectives
Quagliarello
JAMA 2005;293:3061-3062.
FULL TEXT  

Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America
Baddour et al.
Circulation 2005;111:e394-e434.
ABSTRACT | FULL TEXT  

The year in valvular heart disease
Rahimtoola
J Am Coll Cardiol 2005;45:111-122.
FULL TEXT  

Benefits of Surgery for Complicated Endocarditis
JWatch Infect. Diseases 2004;2004:9-9.
FULL TEXT  

Evaluating and Optimizing Outcomes of Surgery for Endocarditis
Durack
JAMA 2003;290:3250-3251.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.